Gamma interferon is not required for arthritis resistance in the murine lyme disease model

被引:42
作者
Glickstein, L
Edelstein, M
Dong, JZ
机构
[1] Tufts Univ New England Med Ctr, Dept Med, Div Rheumatol Immunol, Boston, MA 02118 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1128/IAI.69.6.3737-3743.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lyme arthritis is the most common complication following infection of human individuals with Borrelia burgdorferi sensu stricto. In mice, B. burgdorferi infection leads to arthritis of the tibiotarsal joints. Arthritis severity in mice is under host genetic control, as BALB/c mice developed mild arthritis but C3H/He mice developed severe disease following B. burgdorferi infection. To study the role of gamma interferon (IFN-gamma) in arthritogenesis, targeted mutant mice lacking the IFN-gamma receptor (IFN-gammaR) were infected by inoculation with B. burgdorferi. IFN-gammaR(-/-) and parental 129/SvEv mice developed mild arthritis of similar severity, as determined both by weekly tibiotarsal joint measurements and histopathology at 2 and 5 weeks postinfection, Both strains of mice had the same spirochetal burden in the joints, suggesting that the IFN-gammaR(-/-) mice were not impaired in controlling spirochetal expansion in vivo. The wild-type mice mounted a Th1 response, with a predominance of CD4(+) IFN-gamma (+) T cells observed by flow cytometry. In contrast, the IFN-gammaR(-/-) mice mounted a Th2 response, with a predominance of CD4(+) IL-4(+) T cells. As expected given their cytokine profile, the IFN-gammaR(-/-) mice produced fewer CD8(+) IFN-gamma (+) and MAC-1(+) IL-12(+) cells and less immunoglobulin G2a (IgG2a) than their wild-type counterparts. These results strongly suggest that IFN-gamma is not required for arthritis resistance or as part of an effective immune response against B. burgdorferi.
引用
收藏
页码:3737 / 3743
页数:7
相关论文
共 51 条
[1]   Ablation of interleukin-12 exacerbates lyme arthritis in SCID mice [J].
Anguita, J ;
Samanta, S ;
Barthold, SW ;
Fikrig, E .
INFECTION AND IMMUNITY, 1997, 65 (10) :4334-4336
[2]   Effect of anti-interleukin 12 treatment on murine lyme borreliosis [J].
Anguita, J ;
Persing, DH ;
Rincon, M ;
Barthold, SW ;
Fikrig, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :1028-1034
[3]   The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes [J].
Balasa, B ;
Sarvetnick, N .
JOURNAL OF AUTOIMMUNITY, 1996, 9 (02) :283-286
[4]  
Barthold S. W., 1996, Journal of Spirochetal and Tick-borne Diseases, V3, P22
[5]   EXACERBATION OF LYME ARTHRITIS IN BEIGE MICE [J].
BARTHOLD, SW ;
DESOUZA, M .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :778-784
[6]   LYME BORRELIOSIS IN GENETICALLY RESISTANT AND SUSCEPTIBLE MICE WITH SEVERE COMBINED IMMUNODEFICIENCY [J].
BARTHOLD, SW ;
SIDMAN, CL ;
SMITH, AL .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 47 (05) :605-613
[7]   LYME BORRELIOSIS IN SELECTED STRAINS AND AGES OF LABORATORY MICE [J].
BARTHOLD, SW ;
BECK, DS ;
HANSEN, GM ;
TERWILLIGER, GA ;
MOODY, KD .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :133-138
[8]  
BARTHOLD SW, 1993, AM J PATHOL, V143, P959
[9]   Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon [J].
Brown, CR ;
Reiner, SL .
INFECTION AND IMMUNITY, 1999, 67 (07) :3329-3333
[10]  
Brown CR, 1999, INFECT IMMUN, V67, P1967